Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligenc… (NCT06792175) | Clinical Trial Compass
By InvitationNot Applicable
Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models
United States500 participantsStarted 2025-02-04
Plain-language summary
This study investigates whether AI-driven analysis of speech can accurately predict clinical diagnoses and assess risk for various mental or behavioral health conditions, including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, bipolar disorder, generalized anxiety disorder, major depressive disorder, obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and schizophrenia. We aim to develop tools that can support clinicians in making more accurate and efficient diagnoses.
Who can participate
Age range13 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Participants aged between 16 and 60 years.
✓. Individuals currently undergoing or referred for clinical assessment of mental or behavioral health conditions (including but not limited to ADHD, ASD, BPAD, GAD, MDD, OCD, PTSD, SSD)
✓. Fluent in English
✓. Capable of providing informed consent, or in the case of minors, having a parent or legal guardian who can provide consent on their behalf.
✓. Access to a device (smartphone, tablet, or computer) with a microphone and stable internet connectivity, necessary for completing the speech tasks.
Exclusion criteria
✕. Individuals experiencing acute mental health crises or severe symptoms that would preclude meaningful participation in the study, including acute intoxication.
✕. Severe cognitive impairment or intellectual disability that would prevent understanding of the study procedures or completion of the speech tasks.